AI-generated summary
This narrative review synthesizes near-infrared and red light photobiomodulation in ophthalmology, with emphasis on dry age-related macular degeneration, dry eye disease from meibomian gland dysfunction, and myopia. The authors report biological plausibility and possible functional or anatomical signals in selected conditions. They also state that the clinical evidence is heterogeneous across devices, wavelengths, dosimetry and protocols, and is insufficient to establish the therapy for most indications.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract states that evidence is heterogeneous, data for many ocular indications are preliminary or exploratory, and well-designed randomized controlled trials are still required.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Near-infrared, Dosimetry, Age-related macular degeneration, Reactive oxygen species, Cytochrome c oxidase, Oxidative stress, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.